The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Michael Nicholson, Head of the Division of Academic General and Transplant Surgery at the University of Cambridge, is an esteemed Professor of Transplant Surgery and an Honorary Consultant at Addenbrooke’s Hospital. As the lead for live donor kidney transplantation in Cambridge, he has successfully performed over 7000 laparoscopic live donor nephrectomies and conducted more than 1000 kidney transplants.
Michael is also the Director of the NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation. Leading a dedicated research group, he focuses on advancing renal normothermic machine perfusion, aiming to assess marginal kidneys and deliver pre-transplant allograft therapies. With over 360 published papers, 33 successfully supervised doctorates and an impressive £15 million raised in external grant funding, Michael is a true leader and innovator in the field.
Reflecting on his accomplishments, Michael expresses his gratitude for being bestowed the esteemed ESOT Legacy Award:
“I was both delighted and humbled to hear that ESOT has honoured me with their 2023 Legacy Award. Any success I have had is a result of working with some of the brightest young researchers in transplantation, and I dedicate this award to them. Organ transplantation remains one of the outstanding successes of modern medicine – transforming and extending the lives of many thousands of people – but there are still problems to solve. Fortunately, we are in a time of unprecedented discovery in medical science, with unparalleled opportunities to use technologies such as machine perfusion to increase organ utilisation and improve long-term outcomes.”
